Osteoarthritis Market Poised to Hit $10.74 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Osteoarthritis Market Size Growth Forecast: What to Expect by 2025?
The osteoarthritis market has witnessed significant growth in recent years. It is expected to rise from $6.87 billion in 2024 to $7.49 billion in 2025, at a compound annual growth rate (CAGR) of 9.1%. The growth during the historic period was influenced by factors such as the aging population, the increasing prevalence of obesity, advancements in imaging technologies, and improvements in pain management.

How Will the Osteoarthritis Market Size Evolve and Grow by 2029?
Anticipated for the near future is substantial expansion within the osteoarthritis sector, projecting its valuation to $10.74 billion by 2029, propelled by an impressive compound annual growth rate (CAGR) of 9.4%; this upward trajectory during the forecast timeframe is fundamentally driven by advancements in non-drug interventions, the emergence of disease-modifying osteoarthritis drugs (dmoads), tailored medical treatments, and the increasing adoption of telehealth and remote patient monitoring systems, while key developments shaping this period involve the burgeoning field of regenerative therapies, the proliferation of wearable technologies, the integration of artificial intelligence into diagnostic processes, and the progress of digital healthcare solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

What Drivers Are Propelling the Growth of Osteoarthritis Market Forward?
A surge in health conditions linked to excess weight is anticipated to propel the expansion of the osteoarthritis market in the near future. These weight-related afflictions encompass various ailments stemming from having too much body fat, often resulting from an imbalance where caloric intake surpasses energy expenditure through physical exertion and activity, frequent consumption of large quantities of fast or highly processed foods, and excessive alcohol intake. Such obesity contributes to osteoarthritis by imposing stress on the body's joints, initiating inflammatory responses, and modifying hormonal balances, thereby magnifying the burden carried by these load-bearing structures. To illustrate this trend, data from the World Obesity Federation's World Obesity Atlas 2022 indicates that by the year 2030, one billion individuals globally, representing one in seven males and one in five females, will be classified as obese, with projections showing this figure escalating dramatically to four billion people, or 51% of the world's population, being either overweight or obese by 2035. Consequently, the escalating prevalence of these obesity-correlated disorders is serving as a significant impetus for the advancement of the osteoarthritis market segment.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

Which Emerging Trends Are Transforming the Osteoarthritis Market in 2025?
Leading entities within the osteoarthritis sector are increasingly favoring strategic alliance formation as a method to bolster technological incorporation and broaden their presence across the marketplace. Such alliances generally denote a cooperative linkage forged between several entities, enabling them to pool assets, specialized knowledge, and endeavors toward mutually sought outcomes. Illustratively, in July of 2024, LG Chem, a pharmaceutical firm originating from South Korea, gained entry into the Chinese arena by collaborating with Yifan Pharmaceutical Co., Ltd., a mainland China-based researcher and producer of pharmaceuticals, aiming to introduce Synovian injection for osteoarthritis, which offers comparable therapeutic benefits to conventional multi-dose treatments but necessitates only a singular application. Distinct characteristics of Synovian encompass its substantial molecular weight of 10 million Dalton hyaluronic acid, which boosts both viscoelastic properties and overall joint performance, alongside compelling evidence from Phase 3 clinical trials indicating a marked decrease in knee discomfort, thereby establishing Synovian as a compelling alternative for individuals desiring simplified relief from the manifestations of osteoarthritis.

What Are the Key Segments in the Osteoarthritis Market?
The osteoarthritismarket covered in this report is segmented -

1) By Treatment: Medication; Surgery; Therapy
2) By Diagnosis: Imaging; Joint Fluid Analysis
3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route
4) By Disease Type: Knee Osteoarthritis; Spine Osteoarthritis; Foot And Ankle Osteoarthritis; Shoulder Osteoarthritis; Hand Osteoarthritis
5) By End-User: Hospitals; Medical Institutes

Subsegments:
1) By Medication: Pain Relievers; Corticosteroids; Hyaluronic Acid Injections; Disease-Modifying Osteoarthritis Drugs (DMOADs)
2) By Surgery: Joint Replacement Surgery; Arthroscopy; Osteotomy; Joint Fusion
3) By Therapy: Physical Therapy; Occupational Therapy; Weight Management Programs; Assistive Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

Who Are the Key Players Shaping the Osteoarthritis Market's Competitive Landscape?
Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

What Geographic Markets Are Powering Growth in the Osteoarthritis Market?
North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.